Effect of glucocorticoids on renal dopamine production

European Journal of Pharmacology

Volumn 370, Issue 3, 1999, Pages 271-278

  Aguirre, Jorge A ^a   Ibarra, Fernando R ^b   Barontini, Marta ^a   Arrizurieta, Elvira E ^b   Armando, Ines ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

DOPA (dihydroxyphenylalanine); Dopamine; Glucocorticoid; Natriuresis; Renal function

Indexed keywords

DEXAMETHASONE; DIHYDROXYPHENYLACETIC ACID; DOPA; DOPAMINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY PERFUSION; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CARDIOTONIC AGENTS; DEXAMETHASONE; DIHYDROXYPHENYLALANINE; DIURESIS; DOPAMINE; DOPAMINE AGENTS; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HALOPERIDOL; KIDNEY; MALE; NATRIURESIS; RATS; RATS, WISTAR;

EID: 0032929908     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00121-1     Document Type: Article

References (38)

1. +ATPase activity in the rat proximal convoluted tubule segments. Am. J. Physiol. 252:1987;F39-F45.
2. Armando I., Nowicki S., Aguirre J., Barontini M. A decreased tubular uptake of DOPA results in defective renal dopamine production in aged rats. Am. J. Physiol. 268:1995;F1087-F1092.
3. Arruda J.A.L., Wang L.J., Pahlavan P., Ruiz O.S. Glucocorticoids and the renal Na-H antiporter: role in respiratory acidosis. Regul. Pept. 48:1993;329-336.
4. Ball S.G., Lee M.R. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br. J. Clin. Pharmacol. 4:1977;115-119.
5. Baylis C., Brenner B.M. Mechanism of the glucocorticoid-induced increase in glomerular filtration rate. Am. J. Physiol. 234:1978;F166-F170.
6. Baylis C., Handa R.K., Sorkin M. Glucocorticoids and control of glomerular filtration rate. Semin. Nephrol. 10:1990;320-329.
7. Beauwens, R., Crabbe, J., 1985. Biochemistry of hormone action. In: Kinne, R.K.H. (Ed.), Renal Biochemistry. Elsevier, New York, pp. 308-316.
8. Bertorello A.M., Katz A.I. Short-term regulation of renal Na-K-ATPase activity: physiological relevance and cellular mechanisms. Am. J. Physiol. 265:1993;F743-F755.
9. Clore J.N., Estep H., Ross-Clunis H., Watlington C.O. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486. J. Clin. Endocrinol. Metab. 67:1988;824-831.
10. Eisenhofer G., Goldstein D.S., Stull R., Keiser H.R., Sunderland T., Murphy D.L., Kopin I.J. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4 dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase. Clin. Chem. 32:1986;2030-2033.
11. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am. J. Physiol. 259:1990;F297-F303.
12. + gradient-dependent phosphate-uptake system in renal brush border membrane vesicles. Proc. Natl. Acad. Sci. U.S.A. 79:1982;4932-4936.
13. Garcia D.L., Rennke H.G., Brenner B.M., Anderson S. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J. Clin. Invest. 131:1987;867-874.
14. Goldstein D.S., Grossman E., Armando I., Wolfovitz E., Folio C.J., Holmes C., Keiser H.R. Correlates of urinary excretion of catechols in humans. Biogenic Amines. 10:1993;3-17.
15. Grossman E., Hoffman A., Tamrat M., Armando I., Keiser H.R., Goldstein D.S. Endogenous DOPA and dopamine responses to dietary salt loading in salt-sensitive rats. J. Hypertens. 9:1991;259-263.
16. Grossman E., Hoffman A., Armando I., Abassi Z., Kopin I.J., Goldstein D.S. Sympathoadrenal contribution to plasma DOPA in rats. Clin. Sci. (Lon.). 83:1992;65-74.
17. Guant, R., Chart, J.J., 1962. Mineralocorticoid action of adrenocortical hormone. In Dean, H.W., (Ed.), Handbuch der experimentallen pharmakologie. Springer, Berlin, pp. 514-569.
18. Hegde S.S., Lockhandwala M.F. Renal dopamine and sodium excretion. Am. J. Hypertens. 3:1990;78S-81S.
19. Ibarra F.R., Aguirre J.A., Nowicki S., Barontini M., Arrizurieta E., Armando I. Demethylation of 3-O-methyldopa in the kidney: a possible source for dopamine in urine. Am. J. Physiol. 270:1996;F862-F868.
20. Katz A.I. Corticosteroid regulation of NaK-ATPase along the mammalian nephron. Semin. Nephrol. 10:1990;388-399.
21. + by the kidney. J. Clin. Invest. 46:1967;1999-2011.
22. Lee M.R. Dopamine and the kidney: ten years on. Clin. Sci. (Lond.). 84:1993;357-375.
23. Maddox, D.A., Brenner, B.M., 1996. In: Brenner, B.M. (Ed.), The Kidney. W.B. Sanders, Philadelphia, p. 309.
24. + retention in man is not mediated by the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 72:1991;1060-1066.
25. Nashat F.S., Scholefield F.R., Tappin J.W., Wilcox C.S. The effect of acute changes in haematocrit in the anesthetized dog on the volume and character of the urine. J. Physiol. (London). 201:1969;639-655.
26. Pacak K., Armando I., Komoly S., Fukuhara K., Weise V.K., Holmes C., Kopin I.J., Goldstein D.S. Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. Endocrinology. 131:1992;1369-1376.
27. + ATPase in the rat by adrenal steroids. Am. J. Physiol. 241:1981;F186-F195.
28. Rose S., Jenner P., Marsden C.D. Peripheral phamacokinetic handling and metabolism of L-dopa in the rat: the effect of route administration and carbidopa pretreatment. J. Pharm. Phamacol. 43:1991;325-330.
29. Rossier, B.C., Lawrence, L.G., 1990. In: Seldin, D.W., Giebisch, G. (Eds.), The Kidney: Physiology and Pathophysiology. Raven Press, New York, pp. 1373-1409.
30. Sato T., Minami S., Okabe T., Ogarashi N. Role of renal catecholamines in the control of sodium and water excretion: lack of natriuresis by endogenous dopamine in the rat kidney. Acta Endocrinol. (Copenh.). 116:1987;326-332.
31. Schnermann J., Todd K.M., Briggs J.P. Effect of dopamine on the tubuloglomerular feedback mechanism. Am. J. Physiol. 258:1990;F790-F798.
32. Schoors D.F., Velkeniers B., Dupont A.G. A case of hyperdopaminuria due to increased renal dopamine production. Nephron. 56:1990;329-331.
33. Smith H.W., Finkelstein N., Aliminosa I., Crawford B., Graber M. The renal clearances of substituted hippuric acid and derivatives and other aromatic acids in dog and man. J. Clin. Invest. 24:1945;388-404.
34. Sowers J.R., Crane P.D., Beck F.W.J., McClanahan M., King M.E., Mohanty P.K. Relationship between urinary dopamine production and natriuresis after acute intravascular volume expansion with sodium chloride in dogs. Endocrinology. 115:1984;2085-2090.
35. Thomas, J.A., Keenan, E.J., 1986. Principles of Endocrine Pharmacology, Plenum Medical Book, New York, pp. 214-216.
36. Welbourne T.C. Glucocorticoid control of ammoniagenesis in the proximal tubules. Semin. Nephrol. 10:1990;339-349.
37. Wolfovitz E., Grossman E., Folio C.I., Keiser H.R., Kopin I.J., Goldstein D.S. Derivation of urinary dopamine from plasma dihydroxyphenylalanine (DOPA) in humans. Clin. Sci. (Lon.). 84:1993;549-557.
38. Young M., Raisz L.G. The anthrone method. Proc. Soc. Exp. Biol. Med. 80:1952;771-774.